The value of inflammation-related indicators in chemotherapy efficacy and disease-free survival of triple-negative breast cancer

The value of inflammation-related indicators in chemotherapy efficacy and disease-free survival of triple-negative breast cancer

Abstract Background Systemic inflammation is closely correlated with the progression of cancer. Inflammation-related indicators has been recognized as outcome predictors in triple-negative breast cancer (TNBC). Our study aimed to investigate the predictive value of several inflammation-related indic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jie Zhu, Jiale Cheng, Yuyuan Ma, Ying Wang, Zhonghua Zou, Wenjie Wang, Haihua Shi, You Meng
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Series:	European Journal of Medical Research
Subjects:	Triple-negative breast cancer Inflammation-related indicators Prognostic model Nomogram
Online Access:	https://doi.org/10.1186/s40001-025-02328-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Investigation of survival and prognostic factors in triple negative molecular subtype male breast cancer patients: A population-based study
by: Ahmet Necati Sanli, et al.
Published: (2024-04-01)

Comparative survival outcomes of neoadjuvant and adjuvant therapy in patients with T1c, node-negative, triple-negative breast cancer: A population-based analysis
by: Yi-Zi Zheng, et al.
Published: (2025-02-01)

Triple-negative breast cancer patients treated with subcutaneous mastectomy with immediate reconstruction: single institution experience
by: Artur Bocian, et al.
Published: (2024-12-01)

Deep Learning and Radiomics in Triple-Negative Breast Cancer: Predicting Long-Term Prognosis and Clinical Outcomes
by: Cheng C, et al.
Published: (2025-01-01)

Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk
by: Xinyu Ren, et al.
Published: (2025-04-01)

Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
by: Wei Chen, et al.
Published: (2025-01-01)

Classifications of triple-negative breast cancer: insights and current therapeutic approaches
by: Ziqi Chen, et al.
Published: (2025-02-01)

Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function
by: Annat Raiter, et al.
Published: (2025-02-01)

The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
by: Huayan Gu, et al.
Published: (2025-02-01)

B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer
by: Nicole J. Toney, et al.
Published: (2025-01-01)

Giant triple negative pregnancy-associated breast cancer (PABC) in a young woman: From diagnosis to therapy step by step: A case report
by: Micol Bottalico, et al.
Published: (2025-03-01)

Exploring the Prognostic Role of Trop-2, CD47, and CD163 Expression Levels on Survival Outcomes in Patients with Triple-Negative Breast Cancer
by: Ramazan Oguz Yüceer, et al.
Published: (2025-01-01)

Interleukin-12 Inhibits Tumor Growth and Metastasis Promoted by Tumor-Associated Mesenchymal Stem Cells in Triple-Negative Breast Cancer
by: Babak Jahangiri, et al.
Published: (2024-09-01)

Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker
by: Umay Kiraz, et al.
Published: (2025-01-01)

Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
by: Xin Liu, et al.
Published: (2024-12-01)

Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells
by: Sima Kianpour Rad, et al.
Published: (2025-01-01)

CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line
by: Amr A. Waly, et al.
Published: (2025-01-01)

Mechanistic insights into pachymic acid’s action on triple-negative breast Cancer through TOP2A targeting
by: Ming Liu, et al.
Published: (2025-01-01)

Ethanolic Extract of <i>Averrhoa carambola</i> Leaf Has an Anticancer Activity on Triple-Negative Breast Cancer Cells: An In Vitro Study
by: Oscar F. Beas-Guzmán, et al.
Published: (2024-12-01)

Telomerase and mitochondria inhibition promote apoptosis and TET2 and ANMT3a expression in triple negative breast cancer cell lines
by: Zeinab Mazloumi, et al.
Published: (2024-07-01)

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
by: Wen-yu Cai, et al.
Published: (2025-02-01)

SHP2 promotes the epithelial-mesenchymal transition in triple negative breast cancer cells by regulating β-catenin
by: Shihan Qian, et al.
Published: (2025-01-01)

Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment
by: Tangyi Wang, et al.
Published: (2025-01-01)

A preliminary study on the prognostic significance of cysteine-rich EGF ligand domain 2 protein (CRELD2) in patients with triple negative breast cancer
by: Mehmet Zahid Kocak, et al.
Published: (2025-01-01)

Development of a prognostic model based on four genes related to exhausted CD8+ T cell in triple-negative breast cancer patients: a comprehensive analysis integrating scRNA-seq and bulk RNA-seq
by: Yulin Shi, et al.
Published: (2025-02-01)

A new prognostic model for predicting overall survival and progression-free survival in unresectable hepatocellular carcinoma treated with the FOLFOX-HAIC regimen based on patient clinical characteristics and blood biomarkers
by: Qiuyao Zeng, et al.
Published: (2025-01-01)

Two Novel Compounds Isolated from the Marine Fungal Symbiont of Aspergillus unguis Induce Apoptosis and Cell Cycle Arrest in Breast Cancer Cells: In vitro Study
by: Bashari MH, et al.
Published: (2025-01-01)

hERG activators exhibit antitumor effects in breast cancer through calcineurin and β-catenin-mediated signaling pathways
by: Yan Yu, et al.
Published: (2025-01-01)

A select inhibitor of MORC2 encapsulated by chimeric membranecoated DNA nanocage target alleviation TNBC progression
by: Xiaohan Su, et al.
Published: (2025-04-01)

Prognostic factors in hereditary breast cancer: A review
by: Ziske Maritska, et al.
Published: (2024-08-01)

Programmed Cell Death Ligand 1 (PD-L1) and major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in triple-Negative Breast Cancer
by: Kaewkedsri P, et al.
Published: (2025-02-01)

Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles
by: Shota Yamamoto, et al.
Published: (2025-02-01)

The relationship between mutation carriage of BRCA1/2 and clinicopathological characteristics in women with breast cancer – experience from a diagnostic centre in Turkey
by: Neslihan Duzkale, et al.
Published: (2024-09-01)

The microenvironment cell index is a novel indicator for the prognosis and therapeutic regimen selection of cancers
by: Xian-Yan Yang, et al.
Published: (2025-01-01)

Construction and evaluation of a prognostic model for cervical cancer based on dynamic hematological and clinical features
by: Huangrong Ma, et al.
Published: (2025-02-01)

Discovery of potent allosteric antibodies inhibiting EGFR
by: Léxane Fournier, et al.
Published: (2024-12-01)

Nomogram prediction of overall survival in breast cancer patients post-surgery: integrating SEER database and multi-center evidence from China
by: Yufen Zheng, et al.
Published: (2025-01-01)

Cancer phylogenetic tree inference at scale from 1000s of single cell genomes
by: Salehi, Sohrab, et al.
Published: (2023-07-01)

Tumour DNA methylation markers associated with breast cancer survival: a replication study
by: Elaheh Zarean, et al.
Published: (2025-01-01)

Linear analysis of micromorphic thermoelastic materials with microtemperatures and triple porosity
by: Kansal Tarun
Published: (2024-01-01)